BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29111950)

  • 21. [SIPS--screening instrument for premenstrual symptoms. The German version of Premenstrual Symptoms Screening Tool to assess clinically relevant disturbances].
    Bentz D; Steiner M; Meinlschmidt G
    Nervenarzt; 2012 Jan; 83(1):33-9. PubMed ID: 21221519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of premenstrual impairment among women undergoing prospective assessment for premenstrual dysphoric disorder: a cycle-level analysis.
    Schmalenberger KM; Eisenlohr-Moul TA; Surana P; Rubinow DR; Girdler SS
    Psychol Med; 2017 Jul; 47(9):1585-1596. PubMed ID: 28193300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premenstrual syndrome and premenstrual dysphoric disorders among Jordanian women.
    Albsoul-Younes A; Alefishat E; Farha RA; Tashman L; Hijjih E; AlKhatib R
    Perspect Psychiatr Care; 2018 Jul; 54(3):348-353. PubMed ID: 29215138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample.
    Tschudin S; Bertea PC; Zemp E
    Arch Womens Ment Health; 2010 Dec; 13(6):485-94. PubMed ID: 20449618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premenstrual syndrome and premenstrual dysphoric disorder among Jordanian women.
    Hamaideh SH; Al-Ashram SA; Al-Modallal H
    J Psychiatr Ment Health Nurs; 2014 Feb; 21(1):60-8. PubMed ID: 23445531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A lack of consistent evidence for cortisol dysregulation in premenstrual syndrome/premenstrual dysphoric disorder.
    Kiesner J; Granger DA
    Psychoneuroendocrinology; 2016 Mar; 65():149-64. PubMed ID: 26789492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emotion regulation in women with premenstrual dysphoric disorder.
    Petersen N; London ED; Liang L; Ghahremani DG; Gerards R; Goldman L; Rapkin AJ
    Arch Womens Ment Health; 2016 Oct; 19(5):891-8. PubMed ID: 27155663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice].
    Svojanovská K
    Ceska Gynekol; 2010 Oct; 75(5):474-80. PubMed ID: 21374928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Premenstrual dysphoric disorder and suicide attempts as a correlation among women in reproductive age.
    Shams-Alizadeh N; Maroufi A; Rashidi M; Roshani D; Farhadifar F; Khazaie H
    Asian J Psychiatr; 2018 Jan; 31():63-66. PubMed ID: 29432986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool.
    Wallenstein GV; Blaisdell-Gross B; Gajria K; Guo A; Hagan M; Kornstein SG; Yonkers KA
    J Womens Health (Larchmt); 2008 Apr; 17(3):439-50. PubMed ID: 18328013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perceptions of health and somatic sensations in women reporting premenstrual syndrome and premenstrual dysphoric disorder.
    Craner J; Sigmon S; Martinson A; McGillicuddy M
    J Nerv Ment Dis; 2013 Sep; 201(9):780-5. PubMed ID: 23995034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Premenstrual Dysphoric Disorder (PMDD)].
    Yamada K
    Seishin Shinkeigaku Zasshi; 2015; 117(4):292-8. PubMed ID: 26524841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Iranian version of the Premenstrual Symptoms Screening Tool (PSST): a validation study.
    Hariri FZ; Moghaddam-Banaem L; Siah Bazi S; Saki Malehi A; Montazeri A
    Arch Womens Ment Health; 2013 Dec; 16(6):531-7. PubMed ID: 23974654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of quality-adjusted life years (QALYs) in patients with premenstrual dysphoric disorder (PMDD).
    Yamada K; Kamagata E
    Qual Life Res; 2017 Nov; 26(11):3069-3073. PubMed ID: 28674766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychological factors and premenstrual syndrome: A Spanish case-control study.
    Del Mar Fernández M; Regueira-Méndez C; Takkouche B
    PLoS One; 2019; 14(3):e0212557. PubMed ID: 30840651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Internet-Based Cognitive-Behavioural Intervention for Women with Premenstrual Dysphoric Disorder: A Randomized Controlled Trial.
    Weise C; Kaiser G; Janda C; Kues JN; Andersson G; Strahler J; Kleinstäuber M
    Psychother Psychosom; 2019; 88(1):16-29. PubMed ID: 30783069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder among college students of Bhavnagar, Gujarat.
    Raval CM; Panchal BN; Tiwari DS; Vala AU; Bhatt RB
    Indian J Psychiatry; 2016; 58(2):164-70. PubMed ID: 27385849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Premenstrual Dysphoric Disorder: Epidemiology and Treatment.
    Hantsoo L; Epperson CN
    Curr Psychiatry Rep; 2015 Nov; 17(11):87. PubMed ID: 26377947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menstrual Cycle Disorders in Professional Female Rhythmic Gymnasts.
    Czajkowska M; Plinta R; Rutkowska M; Brzęk A; Skrzypulec-Plinta V; Drosdzol-Cop A
    Int J Environ Res Public Health; 2019 Apr; 16(8):. PubMed ID: 31027248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychosocial Profile of Women with Premenstrual Syndrome and Healthy Controls: A Comparative Study.
    Kleinstäuber M; Schmelzer K; Ditzen B; Andersson G; Hiller W; Weise C
    Int J Behav Med; 2016 Dec; 23(6):752-763. PubMed ID: 27151401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.